1-3 of 3
Laura Hooper
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers

Chris Pepper, Thet Thet Lin, Guy Pratt, Saman Hewamana, Paul Brennan, Louise Hiller, Robert Hills, Rachel Ward, Jane Starczynski, Belinda Austen, Laura Hooper, Tatjana Stankovic, Chris Fegan
Journal: Blood
Blood (2008) 112 (9): 3807–3817.
https://doi.org/10.1182/blood-2008-05-157131
Published: 2008
Includes: Supplemental data
Journal Articles

Mcl-1 Promoter Insertions as an Independent Prognostic Factor for Treatment Free Survival in Chronic Lymphocytic Leukaemia.

Laura Hooper, MD, Julio Delgado, MD, Jane Starczynski, PhD, Jason Evans, MD, Chris Pepper, PhD, Pamela Greenwell, PhD, Chris Fegan, Md, Guy Pratt, MD
Journal: Blood
Blood (2006) 108 (11): 4930.
https://doi.org/10.1182/blood.V108.11.4930.4930
Published: 2006
Journal Articles

Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL

Clinical Trials & Observations
Belinda Austen, Judith E. Powell, Azra Alvi, Ian Edwards, Laura Hooper, Jane Starczynski, A. Malcolm R. Taylor, Christopher Fegan, Paul Moss, Tatjana Stankovic
Journal: Blood
Blood (2005) 106 (9): 3175–3182.
https://doi.org/10.1182/blood-2004-11-4516
Published: 2005